Brookstone Capital Management lifted its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 9.7% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 539,713 shares of the real estate investment trust's stock after purchasing an additional 47,882 shares during the period. Brookstone Capital Management owned about 0.08% of Healthpeak Properties worth $10,913,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the company. Mizuho Bank Ltd. purchased a new stake in shares of Healthpeak Properties in the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd bought a new stake in Healthpeak Properties during the 4th quarter valued at approximately $30,000. Future Financial Wealth Managment LLC purchased a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. S.A. Mason LLC raised its position in shares of Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after acquiring an additional 925 shares in the last quarter. Finally, Covestor Ltd lifted its stake in shares of Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after purchasing an additional 1,152 shares during the period. Hedge funds and other institutional investors own 93.57% of the company's stock.
Healthpeak Properties Stock Down 0.4%
Shares of Healthpeak Properties stock traded down $0.07 on Friday, reaching $18.25. The company's stock had a trading volume of 5,546,828 shares, compared to its average volume of 5,320,639. Healthpeak Properties, Inc. has a 52 week low of $16.64 and a 52 week high of $23.26. The firm's fifty day simple moving average is $17.42 and its two-hundred day simple moving average is $19.02. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $12.68 billion, a price-to-earnings ratio of 45.61, a P/E/G ratio of 2.08 and a beta of 1.03.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. Healthpeak Properties's revenue for the quarter was up 15.9% on a year-over-year basis. During the same period last year, the company earned $0.45 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The company also recently disclosed a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were issued a $0.1017 dividend. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties's payout ratio is currently 305.00%.
Analysts Set New Price Targets
DOC has been the topic of several recent research reports. Wells Fargo & Company reduced their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research note on Monday, June 2nd. Wedbush reduced their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Robert W. Baird lowered their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Evercore ISI dropped their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Finally, Scotiabank decreased their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating for the company in a research note on Monday, May 12th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $23.27.
Read Our Latest Report on DOC
Insider Buying and Selling at Healthpeak Properties
In related news, Director John T. Thomas bought 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were bought at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This trade represents a 0.52% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Scott M. Brinker purchased 11,337 shares of Healthpeak Properties stock in a transaction on Monday, April 28th. The stock was bought at an average price of $17.68 per share, with a total value of $200,438.16. Following the transaction, the chief executive officer owned 201,863 shares of the company's stock, valued at approximately $3,568,937.84. This represents a 5.95% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 29,764 shares of company stock valued at $521,909. 0.23% of the stock is owned by company insiders.
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.